Page last updated: 2024-11-13

guanidinohydantoin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

guanidinohydantoin: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

5-guanidinohydantoin : An imidazolidine-2,4-dione substituted by a guanidino group at position 5. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID45071972
CHEBI ID142614
SCHEMBL ID2124302
MeSH IDM0441255

Synonyms (13)

Synonym
5-guanidinoimidazolidine-2,4-dione
(2,5-dioxo-4-imidazolidinyl)guanidine
guanidinohydantoin
CHEBI:142614
n-(2,5-dioxoimidazolidin-4-yl)guanidine
5-guanidinohydantoin
104184-01-2
5-(amidinoamino)imidazolidine-2,4-dione
1-(2,5-dioxoimidazolidin-4-yl)guanidine
SCHEMBL2124302
DTXSID70662356
n''-(2,5-dioxoimidazolidin-4-yl)guanidine
5-guanidino-hydantoin

Research Excerpts

Overview

Guanidinohydantoin is a hyperoxidized DNA lesion produced by oxidation of 8-oxo-7,8-dihydroguanine.

ExcerptReferenceRelevance
"Guanidinohydantoin (Gh) is a hyperoxidized DNA lesion produced by oxidation of 8-oxo-7,8-dihydroguanine (8-oxoG). "( Thermodynamic consequences of the hyperoxidized guanine lesion guanidinohydantoin in duplex DNA.
Delaney, S; Yennie, CJ, 2012
)
2.06

Dosage Studied

ExcerptRelevanceReference
" The complexity of these dose-response relationships is likely due to the dual role of peroxynitrite as both an oxidant and a nucleophile in competition with water."( Quantitation of four guanine oxidation products from reaction of DNA with varying doses of peroxynitrite.
Tannenbaum, SR; Venkatarangan, L; Wishnok, JS; Yu, H, 2005
)
0.33
" In this study, we have examined the dose-response relationship for the formation of the above four products arising in calf thymus DNA exposed to gamma irradiation, photoactivated rose bengal, and two sources of peroxynitrite."( Comparative analysis of four oxidized guanine lesions from reactions of DNA with peroxynitrite, singlet oxygen, and γ-radiation.
Cui, L; Dedon, PC; Prestwich, EG; Taghizadeh, K; Tannenbaum, SR; Wishnok, JS; Ye, W, 2013
)
0.39
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
guanidinesAny organonitrogen compound containing a carbamimidamido (guanidino) group. Guanidines have the general structure (R(1)R(2)N)(R(3)R(4)N)C=N-R(5) and are related structurally to amidines and ureas.
imidazolidine-2,4-dioneAn imidazolidinone with oxo groups at position 2 and 4.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (5)

PathwayProteinsCompounds
DNA Repair25547
Base Excision Repair3523
Base-Excision Repair, AP Site Formation1716
Depurination107
Cleavage of the damaged purine47

Research

Studies (36)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's13 (36.11)29.6817
2010's22 (61.11)24.3611
2020's1 (2.78)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.90

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.90 (24.57)
Research Supply Index3.61 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.90)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.78%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other35 (97.22%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]